stocks logo

ANDE Stock Price Prediction

Andersons Inc
$
43.260
-0.620(-1.410%)

ANDE Price Prediction Next Week

Analysis and Insights

News Impact:

The announcement by Donald J. Trump regarding tariffs on imported agricultural products starting April 2 is expected to boost domestic production, benefiting companies like Andersons Inc (ANDE). This policy could increase demand for ANDE's products and services, potentially driving growth.

Technical Analysis:

  • RSI: ANDE's RSI is 52.71, indicating a neutral position, not overbought or oversold.
  • MACD: The MACD is slightly positive, suggesting mild upward momentum.
  • Fibonacci Levels: Resistance at $44.16 and support at $41.25.

Recent Price Action:

ANDE closed at $43.03 on March 25, showing slight gains. The stock is approaching the Fibonacci resistance level, which may act as a barrier.

Analyst Sentiment:

Analysts have a target price of $62.50, indicating significant upside potential, though this is a long-term outlook.

Prediction and Recommendation:

Based on the mild bullish indicators and news impact, ANDE is expected to rise to around $44 next week. The recommendation is to buy, but with caution, as the stock approaches resistance. Consider setting a stop-loss if it dips below $41.25.

ANDE Similar Chart Price Prediction

The price of ANDE is predicted to go up -0.9%, based on the high correlation periods with SIRI. The similarity of these two price pattern on the periods is 93.51%.

stocks logo

ANDE

Future prediction

Down: -0.9%

Sign Up to See Future Prediction
stocks logo

SIRI

Down: -0.9%Similarity: 93.51%

ANDE Revenue Forecast

ANDE EPS Forecast

ANDE FAQs

What is ANDE revenue forecast for next quarter?

The market consensus for ANDE's revenue in the upcoming quarter is projected to be approximately $2.849B USD.

What is ANDE eps forecast for next quarter?

ANDE VS S&P500

Andersons Inc
SPDR S&P 500

ANDE Analyst's Forecast

Pooran Sharma

Stephens & Co.

Buy

2025-01-02

Price Target

$60

Upside

+49.78%

Stephens analysts presented the firm's 2025 Best Ideas list, which includes Valley National (VLY), CoStar Group (CSGP), Castle Biosciences (CSTL), Alignment Healthcare (ALHC), Privia Health (PRVA), Vulcan Materials (VMC), South State (SSB), Matson (MATX), Azenta (AZTA), Prog Holdings (PRG), Carvana (CVNA), Blueprint Medicines (BPMC), Truist Financial (TFC), Cognex (CGNX), Fiserv (FI), Hancock Whitney (HWC), SunOpta (STKL), Wingstop (WING), SM Energy (SM), The Andersons (ANDE) and Bank of Marin (BMRC).